For many, the tiredness appears during the first few weeks of treatment or after a dose increase, when the body is still adjusting
ophthalmologic monitoring is advised in high-risk patients Gastroparesis/severe GI disease : GLP-1 agonists are generally not recommended for patients with severe gastrointestinal disease, including gastroparesis Pregnancy : GLP-1 agonists are not recommended during pregnancy
The most distal sections were used to compare axon quantity between groups (Fig
Journal of Animal Science 77: 3289-3295.Google Scholar NAKANISHI, T., HATANAKA, T., HUANG, W., PRASAD, P.D., LEIBACH, F.H., GANAPATHY, M.E
(2000) 279:G12631
In research studies, scientists assess safety through preclinical toxicology models, including cell viability assays and short term exposure observations in animal or in vitro systems